Variant · Snv
CDC5L NM_001253.4(CDC5L):c.2304+132A>G
CI-VAR-00198942Explore in graph →NM_001253.4:c.2304+132A>GClinVar 1230408 rs2273667
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1230408 | Benign | criteria provided, single submitter | 1 | Hepatocellular carcinoma; Uterine corpus endometrial carcinoma; Cholangiocarcinoma; Malignant lymphoma, large B-cell, diffuse; Sarcoma; Uterine carcinosarcoma; Thymoma | germline | 2 | Nov 10, 2018 | clinvar |